As part of the upcoming reauthorization of FDAs medical product user fee programs, direct FDA to prioritize pediatric inclusion efforts by establishing clearer, more consistent policies and practices for including children in clinical trials as early as scientifically and ethically appropriate.
2026 · 3rd Quarter (July 1 - Sep 30)
PEDIATRIC INCLUSION ALLIANCE
Filed by LEAVITT PARTNERS, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Oct 20, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- LEAVITT PARTNERS, LLC
- Filing UUID
- 5e4384b8-9d64-45f1-a36a-b745bb1090e8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
As part of the upcoming reauthorization of FDAs medical product user fee programs, direct FDA to prioritize pediatric inclusion efforts by establishing clearer, more consistent policies and practices for including children in clinical trials as early as scientifically and ethically appropriate.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.